Extension Agreement to Amendment No. 1 to Asset Purchase Agreement among Boston Biomedica, BBI Biotech, and SeraCare Life Sciences

Summary

Boston Biomedica, Inc., BBI Biotech Research Laboratories, Inc., and SeraCare Life Sciences, Inc. have agreed to extend a key deadline in their existing Asset Purchase Agreement. The new deadline for certain provisions is now midnight EST on September 15, 2004, instead of September 2, 2004. This extension is formalized by authorized representatives of all parties and ensures that the terms of the original agreement remain in effect with the updated timeline.

EX-2.3 3 a2143722zex-2_3.htm EXHIBIT 2.3
QuickLinks -- Click here to rapidly navigate through this document

EXHIBIT 2.3

EXTENSION AGREEMENT

Reference is made to that certain Amendment No. 1 to Asset Purchase Agreement (the "Amendment") dated July 20, 2004, by and among Boston Biomedica, Inc., BBI Biotech Research Laboratories, Inc. and SeraCare Life Sciences, Inc.

In accordance with Section 2(c) of the Amendment, the parties hereby further extend the September 2, 2004 date referenced in Section 2(b) of the Amendment to midnight E.S.T. on September 15, 2004, such that the applicable date for purposes of each of Section 11.1(b) and Section 11.1(h) of the Purchase Agreement (as such term is defined in the Amendment) is now midnight E.S.T. on September 15, 2004.

Each of the parties hereto has caused this extension letter to be executed by its duly authorized officers as of this 6^th day of August, 2004.

		SERACARE LIFE SCIENCES, INC.
		By:		/s/ MIKE CROWLEY JR.
		Name:		Mike Crowley Jr.
		Its:		President and CEO
		BOSTON BIOMEDICA, INC.
		By:		/s/ RICHARD T. SCHUMACHER
		Name:		Richard T. Schumacher
		Its:		Chief Executive Officer
		BBI BIOTECH RESEARCH LABORATORIES, INC.
		By:		/s/ RICHARD T. SCHUMACHER
		Name:		Richard T. Schumacher
		Its:		Duly Authorized

QuickLinks

EXTENSION AGREEMENT